The chemotherapy drug paclitaxel, when given to mice, shows signs of impeding the skin disease scleroderma, researchers report. By slowing skin thickening, paclitaxel might offer a treatment for a disease that has defied cure.
Scleroderma results when excess collagen protein accumulates in the skin, rendering it fibrous and inflexible.
Log in
Subscribers, enter your e-mail address for full access to the Science News archives and digital editions.